May 2014

A review on human immunodeficiency virus (HIV) strain candidate vaccine development: Prospect and challenges

Human immunodeficiency virus (HIV) has one of the highest incidence and mortality rates of any infectious disease, with more than 33 million people infected worldwide. Specifically, HIV causes the destruction of helper T cells, ultimately resulting in the suppression of the immune system and leaving its human host susceptible to countless of other pathogenic agents. The development of an effective HIV vaccine has...

Author(s): Akyala Ishaku A., Bright Esyine Shadrack, Olufemi Ajumobi, Adebola Olayinka and Patrick Nguku

May 2014

Improving United Nations Development Programme’s (UNDP’s) research on human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) in Africa

This paper poses methodological and ethical questions on the measures adopted by the human development index (HDI) data in assessing development in Africa, with particular emphasis on human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). It is a well-known fact that these measures are great indicators of development or otherwise. The central position of the paper is that given the difficulty...

Author(s): Ejikeme Nonso Alo

May 2014

External quality assessment: On-site evaluation of HIV testing and counselling sites in Nigeria

A cross-sectional quantitative assessment was conducted to evaluate the quality of testing in 242 human immunodeficiency virus (HIV) testing and counselling (HTC) sites in 25 states including the Federal Capital Territory (FCT) in Nigeria. A checklist assessing eight different quality systems essentials (QSE) adapted from World Health Organization/African Regional Office (WHO/AFRO) laboratory strengthening checklist was...

Author(s): Callista Asamole-Osuocha, Henry Mbah, Simon Cartier, Emmanuel Ojo, Titilope Badru, Mohammed Ibrahim, Iquo Oka, Emmanuel Egwa and Otto Chabikuli